Kazia Therapeutics Ltd reported that Alumni Capital LP, Alumni Capital GP LLC and Ashkan Mapar hold no American Depository Shares as of January 30, 2026. This Amendment No. 5 Schedule 13G/A functions as an exit filing, showing 0 shares and 0% ownership for each reporting person.
The filing lists the reporting persons' principal business address and confirms the General Partner and controlling person relationships; signatures are dated March 30, 2026.
Positive
None.
Negative
None.
Insights
Exit filing confirms Alumni Capital and affiliates no longer hold KZIA ADS.
The Schedule 13G/A (Amendment No. 5) states the Reporting Persons beneficially owned 0 American Depository Shares as of January 30, 2026, and each reports 0% of the class. The filing is described explicitly as an "exit filing."
Operational details include the reporting entities' address and signature dates of March 30, 2026. Subsequent filings would show any future holdings.
Key Figures
Filing type:Schedule 13G/A (Amendment No. 5)Amount beneficially owned:0 sharesPercent of class:0%+2 more
Amount beneficially owned0 sharesas of January 30, 2026
Percent of class0%Alumni Capital LP, Alumni Capital GP LLC, Ashkan Mapar
Signature dateMarch 30, 2026dates of signing by Ashkan Mapar
Issuer addressThree International Towers, Level 24, 300 Barangaroo Ave, SydneyKazia Therapeutics principal executive offices
Key Terms
exit filing, beneficially owned, American Depository Shares
3 terms
exit filingregulatory
"This constitutes an exit filing for the Reporting Person."
beneficially ownedregulatory
"As of January 30, 2026, the Reporting Persons did not beneficially own any of the American Depository Shares"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
American Depository Sharesmarket
"Title of class of securities: American Depository Shares"
American depository shares are U.S.-listed securities that stand in for a foreign company’s ordinary shares, held by a U.S. bank which issues the ADS so investors can trade the foreign stock in U.S. dollars and on U.S. exchanges. Think of them like a locally wrapped version of a foreign product—easier to buy and sell at home—but they still carry risks from currency differences, foreign rules and potential limits on voting rights, so they affect access, liquidity and investment risk.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 5)
KAZIA THERAPEUTICS LTD
(Name of Issuer)
American Depository Shares
(Title of Class of Securities)
48669G105
(CUSIP Number)
01/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
48669G105
1
Names of Reporting Persons
Alumni Capital LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: See Item 4 below. This constitutes an exit filing for the Reporting Person.
SCHEDULE 13G
CUSIP Number(s):
48669G105
1
Names of Reporting Persons
Alumni Capital GP LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: See Item 4 below. This constitutes an exit filing for the Reporting Person.
SCHEDULE 13G
CUSIP Number(s):
48669G105
1
Names of Reporting Persons
Ashkan Mapar
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: See Item 4 below. This constitutes an exit filing for the Reporting Person.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
KAZIA THERAPEUTICS LTD
(b)
Address of issuer's principal executive offices:
Three International Towers, Level 24, 300 Barangaroo Avenue, Sydney NSW, Australia, 2000
Item 2.
(a)
Name of person filing:
This statement is filed by Alumni Capital LP (the "Fund"), Alumni Capital GP LLC (the "General Partner"), and Ashkan Mapar (the "Controlling Person"). The foregoing are collectively referred to herein as the "Reporting Persons".
The Fund holds, has the right to acquire, or has the obligation to acquire, securities of the Issuer. The General Partner serves as the general partner of the Fund. The Controlling person is the control person of the General Partner.
(b)
Address or principal business office or, if none, residence:
The address for the principal business office of each of Alumni Capital LP, Alumni Capital GP LLC, and Ashkan Mapar is 601 Brickell Key Dr., Suite 700, Miami, FL 33131.
(c)
Citizenship:
Alumni Capital LP is a Delaware limited partnership. Alumni Capital GP LLC is a Delaware limited liability company. Ashkan Mapar is a citizen of the United States of America.
(d)
Title of class of securities:
American Depository Shares
(e)
CUSIP No.:
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
As of January 30, 2026, the Reporting Persons did not beneficially own any of the American Depository Shares representing ordinary shares of Kazia Therapeutics Limited. Accordingly, this Schedule 13G/A constitutes an exit filing for the Reporting Persons.
(b)
Percent of class:
Alumni Capital LP - 0%
Alumni Capital GP LLC - 0%
Ashkan Mapar - 0%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Alumni Capital LP - 0
Alumni Capital GP LLC - 0
Ashkan Mapar - 0
(ii) Shared power to vote or to direct the vote:
Alumni Capital LP - 0
Alumni Capital GP LLC - 0
Ashkan Mapar - 0
(iii) Sole power to dispose or to direct the disposition of:
Alumni Capital LP - 0
Alumni Capital GP LLC - 0
Ashkan Mapar - 0
(iv) Shared power to dispose or to direct the disposition of:
Alumni Capital LP - 0
Alumni Capital GP LLC - 0
Ashkan Mapar - 0
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Alumni Capital LP
Signature:
/s/ Ashkan Mapar
Name/Title:
Ashkan Mapar, Manager of Alumni Capital GP LLC, General Partner of Alumni Capital LP
Date:
03/30/2026
Alumni Capital GP LLC
Signature:
/s/ Ashkan Mapar
Name/Title:
Ashkan Mapar, Manager of Alumni Capital GP LLC, General Partner of Alumni Capital LP
Date:
03/30/2026
Ashkan Mapar
Signature:
/s/ Ashkan Mapar
Name/Title:
Ashkan Mapar, Manager of Alumni Capital GP LLC, General Partner of Alumni Capital LP
What does the KZIA Schedule 13G/A Amendment No. 5 state about Alumni Capital's holdings?
The filing states Alumni Capital LP and related entities beneficially own 0 American Depository Shares as of January 30, 2026, representing 0% of the class.
Who filed the Schedule 13G/A amendment for KZIA?
The statement was filed by Alumni Capital LP, Alumni Capital GP LLC, and Ashkan Mapar, who are identified as the Fund, General Partner, and Controlling Person.
What is an "exit filing" in the KZIA Schedule 13G/A?
An "exit filing" indicates the reporting persons no longer beneficially own the registered class. Here, the filing explicitly describes itself as an exit filing showing zero holdings.
What dates are relevant in the KZIA filing for ownership and signatures?
The ownership position is stated as of January 30, 2026. The document includes signature dates of March 30, 2026 from the reporting person representative.
Where is the reporting persons' principal business address listed?
The address for Alumni Capital LP, Alumni Capital GP LLC, and Ashkan Mapar is listed as 601 Brickell Key Dr., Suite 700, Miami, FL 33131 in the filing.
